[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dipexium Pharmaceuti (DPRX)

Dipexium Pharmaceuti (DPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dipexium Pharmaceuti 14 WALL ST. SUITE 3D NEW YORK NY 10005 USA

www.dipexiumpharmaceuticals.com P: 212-269-2834

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Dipexium Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops and commercializes Locilex (TM), small peptide topical antibiotic for the treatment of certain mild and moderate skin infections in superficial wounds, including infected decubitus ulcers, infected burns, infected surgical wounds, and nasal colonization of methicillin-resistant staphylococcus aureus. Dipexium Pharmaceuticals, LLC is based in White Plains, New York.

Key Statistics

Overview:

Market Capitalization, $K 15,048
Shares Outstanding, K 11,230
% of Insider Shareholders 47.70%
% of Institutional Shareholders 3.00%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -21,320 K

Growth:

1-Year Return -86.27%
3-Year Return -86.11%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/10/17
Earnings Per Share ttm -0.97
EPS Growth vs. Prev Qtr 13.46%
EPS Growth vs. Prev Year 8.16%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

DPRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -92.98%
Return-on-Assets % -86.72%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.94
Book Value/Share 0.00
Interest Coverage 0.00
60-Month Beta 1.90
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.